Enspire Dbs Therapy Announces $17.6 Million Series B Financing To Advance The Development Of Deep Brain Stimulation (Dbs) Plus Rehabilitation For Stroke Patients
Amount Raised
$17.6 Million
Round Type
Series B
ClevelandBiotechnologyHealth CareMedicalInvestors
Description
Enspire DBS Therapy, Inc., (Enspire) a clinical stage company developing an implantable neuromodulation therapy for post-stroke recovery, announced today that it raised $17.6 million of committed capital in a Series B financing led by existing investor, Cleveland Clinic. Also participating in the round were JobsOhio Growth Capital Fund and an undisclosed investor.
Quick answer
Enspire raised $17.6 Million in a Series B round, dated August 1, 2023. Investors: Jobs Ohio Growth Capital Fund and Cleveland Clinic. Enspire is based in Cleveland, Ohio, United States.
- How much did Enspire raise?
- Enspire raised $17.6 Million in a Series B round on August 1, 2023.
- Who invested in Enspire?
- Jobs Ohio Growth Capital Fund and Cleveland Clinic are named as investors in this round.
- What does Enspire do?
- Enspire DBS Therapy, in partnership with Cleveland Clinic and Boston Scientific, is developing a proprietary deep brain stimulation (DBS) therapy to restore motor function for stroke survivors living with disability.
- Where is Enspire based and how big is it?
- Enspire is based in Cleveland, Ohio, United States. Fundz records about 10 employees.
- Who are the decision-makers at Enspire?
- Fundz holds 2 contacts at Enspire. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Enspire that raised within 45 days of this round, from Fundz verified event records.
- Sempre Health raised $20M (Funding Round) on September 13, 2023.
- AWAK Technologies raised $20M (Funding Round) on September 13, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Streamex Corp. raised $794K (Seed) on September 12, 2023.
- VeinWay raised an undisclosed amount (Series A) on September 7, 2023.
- Aptose Biosciences raised $3M (Seed) on September 6, 2023.
Who to call at Enspire, and when
A new round usually means Enspire is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Enspire raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enspire, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enspire. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enspire raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEnspire raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.